COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 266

Article download: 116

Indian Journal of Obstetrics and Gynecology Research


Study of management of postpartum anemia with inj ferric carboxymaltose


Full Text PDF Share on Facebook Share on Twitter


Research Article

Author Details : Vidya Gaikwad, Shruti Mallya, Pankaj Salvi*

Volume : 6, Issue : 3, Year : 2019

Article Page : 366-368


Suggest article by email


Abstract

Introduction: Women of reproductive age are more prone to iron deficiency anemia (IDA) due to blood
loss or increased iron demand due to menstruation, pregnancy and lactation. With this background, the
study aims to find the safety and efficacy of intravenous ferric carboxymaltose in the treatment of iron
deficiency anemia in women who has just delivered.
Materials and Methods: The present study was a Prospective interventional hospital based therapeutic
trial conducted on postpartum anemic women of more than 18 years of age with HB <10gm> the study period. Intravenous ferric carboxymaltose (FCM) was given to the anemic women who has just
delivered. Total 500 mg/10 ml in 250 ml of 0.9% normal saline was given over 15-20 min.
Results: Mean hemoglobin level before intravenous ferric carboxymaltose was 8.42 0.61 gm% while it
was 10.03 0.74 gm% after treatment. Before treatment, 17(28.3) women had Hb between 7.1 to 8 gm%
which was decreased to 3(5) after giving intravenous ferric carboxymaltose. There was significant rise in
Hb level, Serum ferritin, MCV and MCHC after 2 weeks of treatment.(p < 0> Conclusion: We conclude from our study that Intravenous ferric carboxymaltose increses Hb levels and
restores iron stores better in a shorter period of time. It also elevates serum ferritin levels. No serious
adverse effects were noted and it was well tolerated by the patients. Patient compliance was better due to
shorter hospital stay and single dose infusion.

Keywords: Ferric Carboxymaltose, Postpartum Anemia, Intravenous Injection.

Doi : 10.18231/j.ijogr.2019.079

How to cite : Gaikwad V , Mallya S, Salvi P , Study of management of postpartum anemia with inj ferric carboxymaltose. Indian J Obstet Gynecol Res 2019;6(3):366-368

Copyright © 2019 by author(s) and Indian J Obstet Gynecol Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)